Biotechnology
Performance Capabilities
Leading Next-Generation Therapies
Geneva researchers have vast experience in developing biologics and cell therapies, with expertise in areas including:
- Access to BSL-2 and BSL-3 facilities
- Bioengineering
- Creation of educational initiatives, including biotechnology courses
- Development of biotechnologies and therapeutics
- Development of training opportunities
- Expansion of maturing technologies for advanced development
- Expediting product development through preclinical and clinical
- Onsite and rapid biofabrication
- Stem cell therapy applications such as wound healing
- Utilization of medical simulation
USU-4D Bio3 Center for Biotechnology
The Uniformed Services University Biotechnology, Biomanufacturing, and Bioprinting Center (USU-4D Bio3 Center for Biotechnology) promotes the development and application of advanced bioprinting, biofabrication, and biomanufacturing technologies for research pursuant to Department of Defense priorities and for translation to clinical medical defense care and training solutions.
Learn moreGeneva Expertise
Researcher of the Year
LTC (Ret.) Luis Alvarez, PhD
Dr. Alvarez is leading innovative research in developing biologics and cell therapies in regenerative medicine.
Learn More
Learn more about the USU-4DBio3 Center for Biotechnology, its capabilities, and ways to get involved.
View the videoResearch Indications
Geneva has diverse experience in managing biotechnology programs in areas including:
3D bioprinting
Biofabrication
Biomaterial formulation and injection
Biobanking
Biosensors
Drug and vaccine development
Environmental and occupational health
Gene therapy
Medical devices
OrthoBiologics
Personalized multi omics screening
Stem cell and minimally modified cell-based therapies
Tissue engineering